Wednesday, November 11, 2026

AI Systems Solve Complex Math Problems in Hours, Push Toward Automated Research Workflows

AI tools like Axiom Math's Axplorer now solve complex mathematical problems in hours on single machines, while OpenAI develops systems capable of working indefinitely like human researchers. The technology promises accelerated scientific breakthroughs, though experts note current limitations in generating truly novel research ideas.

LM Salvado

March 26, 2026

AI Systems Solve Complex Math Problems in Hours, Push Toward Automated Research Workflows
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Axiom Math's Axplorer solves complex mathematical problems in hours on single machines, marking a shift from AI as research assistant to autonomous problem solver.1 The tool addresses mathematician frustration with DeepMind's AlphaEvolve, which requires special access and manual problem submission.1

OpenAI is building AI systems capable of working indefinitely in a coherent way, functioning as automated research interns.2 Chief Scientist Jakub Pachocki expects these systems won't match human intelligence across all dimensions by 2028, but emphasizes they don't need to. "You don't need to be as smart as people in all their ways in order to be very transformative," he said.2

The technology targets low-hanging fruit in research. "There are tons of problems that are open because nobody looked at them, and it's easy to find a few gems you can solve," said François Charton, highlighting opportunities in neglected research areas.1

Automated research systems promise knock-on effects across technology development and financial markets as discovery timelines compress. Drug development, materials science, and algorithm optimization could accelerate as AI handles iterative testing and hypothesis generation that currently consumes researcher time.

Current limitations remain in truly novel ideation. The systems excel at solving defined problems and exploring established problem spaces, but generating breakthrough research questions still requires human insight. This positions AI as workflow automation rather than complete researcher replacement in the near term.

The shift raises policy questions governments must address, Pachocki noted, particularly around research access, intellectual property, and the changing role of human researchers.2 As single-machine solutions like Axplorer democratize access to advanced mathematical tools, the barriers between cutting-edge research capabilities and everyday practitioners continue falling.

The technology's commercial trajectory suggests a two-tier market: open tools like Axplorer competing against closed systems requiring institutional access. This mirrors broader AI commercialization patterns where deployment speed and accessibility increasingly determine market winners.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleMIT Technology Review
    OpenAI is throwing everything into building a fully automated researcher
  2. [2]News articleMIT Technology Review
    This startup wants to change how mathematicians do math
  3. [3]Press releaseGlobeNewswire· March 24, 2026
    0G Labs Trained World's Largest Decentralized AI Model at 107B Parameters in 2025 - Eight Months Before This Week's Industry Headlines
  4. [4]News articleYahoo Finance· January 22, 2026
    4 Medical Supply Stocks Poised to Gain in a Prospering Industry
  5. [5]News articleYahoo Finance· February 24, 2026
    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases
  6. [6]Press releaseGlobeNewswire· March 13, 2026
    Agero Enters into Agreement to Acquire Urgently, for $5.50 in Cash Per Share, Expanding Tech-Driven Roadside Assistance Across Automotive, Fleet, Rental, and Insurance Markets
  7. [7]News articleYahoo Finance· November 26, 2025
    AI to Reshape the Global Technology Landscape in 2026, Says TrendForce
  8. [8]News articleMIT Technology Review
    Can quantum computers now solve health care problems? We’ll soon find out.
  9. [9]News articleYahoo Finance· March 25, 2026
    In a World’s First, Pulsar Fusion Demonstrates Its “Sunbird” Nuclear Fusion Rocket’s “First Plasma” at MARS Conference Hosted by Jeff Bezos
  10. [10]News articleYahoo Finance· March 25, 2026
    Infosys to Acquire Leading Insurance Consulting Technology Company, Stratus
  11. [11]News articleYahoo Finance· March 25, 2026
    Jury Orders $3 Million in Punitive Damages Against Meta and YouTube in Landmark Social Media Addiction Trial
  12. [12]News articleYahoo Finance· January 30, 2026
    Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com